Target intelligence / Profile preview

Sec7 domain-containing guanine-nucleotide exchange factor

Molecular classification
Enzyme, Guanine nucleotide exchange factor (GEF), Regulatory protein
01

Overview

The **Sec7 domain-containing guanine-nucleotide exchange factors** are a family of enzymes characterized by the presence of a Sec7 domain, which catalyzes the exchange of GDP for GTP on ADP-ribosylation factor (ARF) GTPases, primarily involved in regulating vesicular protein trafficking and membrane remodeling[1][2][4]. These proteins function as critical regulators in the secretory and endosomal pathways, especially at the Golgi apparatus and trans-Golgi network, where they facilitate the recruitment of coat proteins and clathrin adaptors for vesicle formation and transport[5][6]. The Sec7 domain is highly conserved and defines the catalytic core of these exchange factors, while other domains (such as pleckstrin homology domains) assist in membrane association and regulation[4]. Because their activity is essential for proper cellular trafficking, Sec7 domain-containing GEFs are considered therapeutic targets, particularly in diseases marked by altered vesicular transport, but their fundamental roles in cell physiology also present therapeutic and safety challenges[6].

Other names
Sec7 domain-containing GEFARF guanine-nucleotide exchange factorArf-GEFARF-GEPARF-GEP100GBF1BIG1BIG2
02

Mechanism of action

Inhibition of guanine nucleotide exchange activity on ARF GTPases (typical action of BFA on sensitive Sec7-GEFs)

03

Biological functions

Signal transductionRegulation of ARF GTPasesVesicle traffickingMembrane remodelingProtein transport through the Golgi
04

Disease associations

CancerNeurological disordersOther (given their roles in vesicular trafficking and cell signaling, involvement in various diseases is likely, but specific diseases depend on the GEF subtype)
05

Safety considerations

Targeting vesicular trafficking may result in broad effects on protein secretion, membrane dynamics, and cell viabilityInhibition (e.g. by BFA) can cause collapse of the Golgi apparatus and disruption of essential cellular processes
06

Interacting drugs

Brefeldin A (BFA) (an inhibitor that targets some, but not all, Sec7 domain-containing GEFs)

1 more in the full profile.

07

Biomarkers

Altered localization or expression levels of certain Sec7 domain-containing GEFs (e.g. GBF1, BIG1, BIG2) may serve as potential biomarkers in cancer and neurodegenerative diseases, though none are widely used clinically at present

Beyond the preview

Go deeper on Sec7 domain-containing guanine-nucleotide exchange factor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sec7 domain-containing guanine-nucleotide exchange factor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call